Consensus EMEIS Deutsche Boerse AG

Stocks

OPA1

FR001400NLM4

Healthcare Facilities & Services

Real-time Estimate Tradegate 20:43:09 08/10/2026 BST			5-day change	1st Jan Change
9.925 ^EUR	-0.45%		-6.88%	-30.11%

10-05	Emeis completes its exit from Latin America
10-05	Emeis Closes EUR111 Million Sale of Latin American Operations	MT

cd41eaff32cbc55d1046a21b78df7.fFOwJf-7Fuv0CYUgU6yXmstZSvfIAQB8QhkvUGLDpso.KBLxcKmNXY-WR-hiJMLuraQNELWAMEoWb19CEyq7y4IrKfNfvo5iirZksQ~71c6bb4f9d91787cce8adf028c50a847

Analysts' recommendations: EMEIS

08-03	Emeis: Operations confirmed as under control
07-31	Emeis: Strong semester: Moving the right way
04-28	Emeis holds firm with backing from TP Icap Midcap
04-09	Emeis: Pivot from firefighting to foundations
03-26	Limited 2026 energy impact; inflation remains in focus
03-04	AlphaValue/Baader Europe Lifts Emeis Rating as Operations Normalize; Estimates Revised on Preliminary FY25 Results	MT
03-03	Emeis: Opinion change, from Sell to Reduce
02-18	Emeis: Operational beat and deleveraging milestones tempered by cautious 2026 guidance
29/10/25	Emeis: Opinion change, from Sell to Reduce
29/10/25	Emeis: Good momentum expected to extend
30/09/25	Emeis: Oddo BHF raises its target price
24/09/25	Emeis: Integrating the latest strategic real-estate partnership
04/08/25	Emeis: AlphaValue still a selller
04/08/25	Emeis: Encouraging updates in asset disposals
04/06/25	Emeis: Opinion change, from Sell to Reduce
22/04/25	Emeis: Justifying disposal progress is key
13/02/25	Emeis: Opinion change, from Sell to Add
07/02/25	Emeis: FY24: on the right track
20/11/24	Emeis: Opinion change, from Buy to Add
13/11/24	Emeis: Positive Q3 lifted by a pricing and occupancy recovery; asset sales well on-track
04/10/24	Emeis: Farewell to profit warnings (?)
03/09/24	Emeis: Target cut by -32.9%
29/07/24	Emeis: Profit warning again (and again)
04/06/24	Orpea: Integrating the detailed FY23 figures
15/05/24	Orpea: Challenging recovery in France, adequate elsewhere

More recommendations

Residential & Long-Term Care

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CVS HEALTH CORPORATION					+31.62%
	HCA HEALTHCARE, INC.					+4.58%
	NATERA, INC.					-3.95%
	FRESENIUS SE & CO. KGAA					+28.42%
	LABCORP HOLDINGS INC.					+10.33%
	QUEST DIAGNOSTICS INCORPORATED					+9.25%
	DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY					+17.08%
	TENET HEALTHCARE CORPORATION					+9.81%
	REDE D'OR SÃO LUIZ S.A.					+10.02%
	Average					+13.02%
	Weighted average by Cap.					+14.36%